Top Growth Driver in Obeticholic Acid Market 2025: Rising Liver Disease Prevalence Fueling Market Growth

The Business Research Company's Obeticholic Acid Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, May 15, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034

The obeticholic acid market has displayed remarkable growth in recent years and is slated to continue this upward trend. The market size, which stood at $0.90 billion in 2024, is projected to touch $1.02 billion in 2025, indicative of a compound annual growth rate CAGR of 13.4%. Factors fueling this growth over the historical period include a rise in the incidence of primary biliary cholangitis PBC and nonalcoholic steatohepatitis NASH, expansion of healthcare infrastructure in emerging markets, increased diagnostics and screening for liver diseases, and growing healthcare expenditure combined with an investment influx in liver disease research.

Is the Obeticholic Acid Market Set to Witness Substantial Growth?
Looking ahead, the obeticholic acid market size indicates a continued trajectory of rapid growth. Experts predict that it will rise to $1.67 billion in 2029, with a CAGR of 13.1%. Increased prevalence of PBC and NASH, a growing demand for state-of-the-art liver disease treatments, enhanced consciousness about liver diseases and available treatments, an expanded global healthcare access, primarily in emerging markets, and a rising awareness of liver diseases and available treatments are anticipated to be the drivers of growth in the forecast period.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22079&type=smp

Significant market trends include increased adoption for NASH treatment, partnerships and collaborations focused on development, integration of digital health tools for monitoring and compliance, a shift towards non-alcoholic fatty liver disease NAFLD treatment, and advances in liver disease biomarkers and diagnostic technologies.

What Drives The Obeticholic Acid Market Growth?
A key factor contributing to market growth is the rising prevalence of liver diseases. These ailments affect the liver's ability to function optimally. Liver diseases are generally attributed to excessive alcohol consumption, which can lead to liver inflammation, cirrhosis, and liver failure due to damage to liver cells and impairment of the organ’s functionality. Obeticholic acid is of great benefit to liver disease patients due to its ability to activate the farnesoid X receptor FXR, which reduces bile acid accumulation, diminishes liver inflammation, slows down fibrosis progression, and ultimately enhances liver functioning.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/obeticholic-acid-global-market-report

Who Are The Key Players In The Obeticholic Acid Market?
Prominent industry players include Pfizer Inc., GlaxoSmithKline GSK, Gilead Sciences Inc., Amgen Inc., Genfit, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, WuXi AppTec, Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Dr. Reddy’s Laboratories, Lupin Limited, Hepalink Pharmaceutical Group, Alembic Pharmaceuticals, Intercept Pharmaceuticals Inc., Enanta Pharmaceuticals, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., and Zydus Cadila.

What Are The Emerging Trends In The Obeticholic Acid Market?
Major industry players are focusing on the development of innovative products such as farnesoid X receptor FXR agonist to bolster liver disease treatment and improve patient outcomes. FXR agonists are compounds that activate the FXR, a nuclear receptor implicated in the regulation of bile acid metabolism, inflammation, and fibrosis in the liver. FXR agonists help improve liver function and are used in treating conditions such as PBC and NASH.

How Is The Obeticholic Acid Market Segmented?
The market segmentation for the obeticholic acid market is as follows:
1 Product type: tablets, capsules, and other product types.
2 Distribution channel: hospital pharmacies, retail pharmacies, and online pharmacies.
3 Application: primary biliary cholangitis, nonalcoholic steatohepatitis, and other applications.
Sub-segments:
1 Tablets: immediate-release tablets and extended-release tablets.
2 Capsules: soft gelatin capsules and hard gelatin capsules.
3 Other product types: oral suspensions and injectable formulations.

What Is The Regional Analysis Of Obeticholic Acid Market?
North America dominated the obeticholic acid market in 2024, while Asia-Pacific is tipped to be the region with the steepest growth trajectory in the forecast period. The pertinent regions accessed in the market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Food Acidulants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/food-acidulants-global-market-report

Feed Acidifiers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/feed-acidifiers-global-market-report

Glutamic Acid Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/glutamic-acid-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research, and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X